Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections (COMPAS)

Pfizer

Status: Completed

Conditions: Respiratory Tract Infections

Treatments: Drug: Azithromycin

Study type: Observational

Funder types: Industry

Identifiers

NCT00939185

A0661182

Details and patient eligibility

About

The objective of this study was to obtain data on the safety, tolerability and compliance with Zithromax in children with bacterial infections of the upper and lower respiratory tract.

Full description

Patients were recruited from the outpatient departments of the participating sites/hospitals/clinics.

Enrollment: 400 patients

Sex: All

Ages: 1 to 14 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with respiratory tract infections that received azithromycin according to the approved SPC as this was a non-interventional study.

Exclusion criteria

• According to the approved Summary of Product Characteristics (SPC) for Azithromycin as this was a non interventional study.

Trial design

400 participants in 1 patient group

Azithromycin group

Treatment:

Drug: Azithromycin